Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 361-380 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 361 | Romanian InSpace Engineering lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only provides older membership context that Romanian InSpace Engineering was part of the consortium that developed the EMISAR satellite via article; that is insufficient for a current positive thesis within this ranking window. Why now: No why-now catalyst is evidenced because there are no retained 90-day evidence. Caveats: Reviewed evidence references but provides no. Single historical membership-support mention only. No retained evidence after recent evidence window. |
| 362 | Safran lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not provide direct positive company-specific evidence within the available 90-day evidence set. Only older or contextual references are cited in the membership rationale, including thematic propulsion or battery market reports and a reference to expanded small-satellite propulsion manufacturing, but no direct post-recent evidence window evidence is available for scoring. Why now: There is no current catalyst in the reviewed sources. Coverage debug shows 270 article IDs considered but 0 article IDs after recent evidence window and 0 evidence available after dedupe, so recency-based thesis formation is not supported. Caveats: Membership rationale references article IDs 2026-04, and, but no are provided in the reviewed sources, so they cannot be cited as factual scoring evidence under the the evidence standard. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff. |
| 363 | SatLeo Labs lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence rationale says SatLeo Labs raised seed funding for a multispectral and thermal Earth observation constellation, but no retained article/evidence are available here to support a stronger opportunity ranking. Why now: No retained within the recent evidence window evidence are provided, so there is no reviewed sources-supported why-now beyond cohort inclusion rationale. Caveats: Only membership rationale is available; no citeable retained evidence. Small-company universe but zero available evidence after recent evidence window. |
| 364 | SciTec lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources say AI software came from a SciTec subsidiary in connection with Firefly's lunar imaging service, but this is only supporting article context without retained direct evidence, so it does not support a strong long-horizon opportunity thesis for SciTec itself. Why now: No current catalyst is established because the reviewed sources retains no company-specific evidence after the 90-day filter. Caveats: Phase-2 rationale references, but no or retained summary is available in the reviewed sources. Support level is provisional single-article context. No direct company-specific positive or negative evidence remain after recent evidence window. |
| 365 | SEALSQ Corp lowweak | Opp 1 Risk 2 | Thesis: Reviewed evidence membership rationale says SEALSQ is directly involved with WISeSat in a planned 100-satellite QSOC constellation and post-quantum satellite launches, which could indicate long-horizon strategic relevance, but no usable direct positive evidence or article survive the 90-day served evidence set in these reviewed sources. Why now: Why now is weak because the 90-day reviewed sources contain no available evidence after recent evidence window for SEALSQ, despite article history existing in the broader corpus. Caveats: No direct positive or negative evidence available after recent evidence window. Membership rationale references article IDs and, but the reviewed sources provide no for them, so they cannot be cited as factual support under the the evidence standard. |
| 366 | SEALSQ Corp lowweak | Opp 1 Risk 1 | Thesis: Reviewed evidence context links SEALSQ to post-quantum payload development with WISeSat, but there is no retained direct positive evidence inside the 90-day recent evidence window to support a 1 year+ opportunity thesis. Why now: There is no usable current evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0 following the March 29, 2026 cutoff. Caveats: No surviving recent evidence window-qualified evidence. Space relevance in reviewed sources rationale does not establish direction. |
| 367 | SES S.A. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources membership rationale places SES in satellite communications and infrastructure contexts, but there are no available within the recent evidence window evidence or article details to support a directional opportunity thesis for this screen. Why now: Why-now is weak because no reviewed evidence are available after recent evidence window, so recency and catalysts cannot be assessed from the reviewed sources. Caveats: Membership rationale references and, but no corresponding available article summaries or evidence are provided. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Cohort membership does not establish opportunity. |
| 368 | Sidus Space Inc. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources' membership rationale references payload and agreement expansion activity, but no retained within the recent evidence window direct evidence or article summaries are available here to support a positive investment-style thesis. Why now: There is no retained dated company evidence after the 90-day recent evidence window; timing support for a 1 year+ thesis is absent in the reviewed sources. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. The membership rationale mentions article IDs, and, but no or retained evidence content are provided in these reviewed sources. |
| 369 | SkyFi lowweak | Opp 1 Risk 1 | Thesis: No direct positive evidence is available, so there is no supportable upside thesis from these reviewed sources alone. Why now: Membership rationale says SkyFi was mentioned as a commercial access partner for Vantor's satellite imagery constellation in article, but this is only contextual and no or direct evidence are provided. Caveats: Partner context is weaker than direct company evidence. No evidence available after recent evidence filtering. Referenced has no in the reviewed sources. |
| 370 | Skyfora lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only says Skyfora appears in a funding roundup with a €6.5M raise, but no retained direct evidence or article summaries are provided after the 90-day recent evidence window, so there is not enough evidence to support a positive 1 year+ thesis. Why now: No within the recent evidence window company-specific catalyst is provided. The reviewed sources reports zero reviewed evidence after the 90-day cutoff for Skyfora, so recency is insufficiently grounded. Caveats: Phase-2 rationale references a €6.5M raise tied to: but no representative article, or retained evidence row is provided in these reviewed sources, so it cannot be used as direct scored evidence. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership review status is not directional proof. |
| 371 | Solestial Inc. lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable from these reviewed sources because no retained direct positive evidence is provided inside the recent evidence window. Why now: No current catalyst can be established from the reviewed sources; the company has zero evidence after recent evidence window. Caveats: Phase-2 rationale says York Space Systems acquired Solestial and cites: but no article summary or is provided here, so it cannot be used as cited factual support. Coverage debug shows 4 articles considered and 0 article IDs after recent evidence window. Absence of evidence is not positive or negative proof. |
| 372 | Solstar Space Company lowweak | Opp 1 Risk 1 | Thesis: The membership rationale says Solstar's Deke Space Communicator operated in orbit and achieved TRL 9 with two-way data transmission and onboard Wi-Fi, which could imply commercialization potential, but no direct positive evidence or article summaries are available for scoring in these reviewed sources. Why now: The reviewed sources contain no reviewed evidence after recent evidence window for this company, preventing a recency-based 1 year+ ranking judgment beyond watchlist status. Caveats: Membership rationale references article, but no direct summary or evidence row is available here for citation. Coverage debug shows zero available evidence after recent evidence window. Private-company status is not itself positive or negative. |
| 373 | Space Systems/Loral, LLC (SSL) lowweak | Opp 1 Risk 1 | Thesis: SSL is referenced in membership rationale as appearing among key players in an optical satellite market report, but that is only article-level industry context and no direct within the recent evidence window evidence is available. Why now: No current catalyst can be established because coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window. The rationale cites: without a in these reviewed sources. Caveats: Only industry-report context is referenced in membership rationale. No direct event/fact evidence survived the recent evidence window. |
| 374 | Space42 lowweak | Opp 1 Risk 1 | Thesis: Space42 is described in membership rationale as operating a SAR Earth observation constellation with satellites entering full operation, but the reviewed sources retains no direct evidence or article summaries within the recent evidence window to support a current opportunity ranking. Why now: Why now is weak because coverage data shows no articles after recent evidence window and no evidence after recent evidence window. Caveats: Membership rationale references article IDs but no are provided, so they cannot be used as cited factual support here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. |
| 375 | SpaceLocker lowweak | Opp 1 Risk 1 | Thesis: There is not enough retained evidence in the recent evidence window to underwrite a durable opportunity case, despite membership rationale describing a first shared satellite mission. Why now: No article-level or event-level evidence were retained after the March 29, 2026 recent evidence window cutoff; recency for the membership rationale is therefore unusable for ranking. Caveats: Membership rationale references article, but no representative article summary or retained evidence row is included. Single-article universe with zero retained rows limits confidence materially. |
| 376 | SpaceLogistics (Northrop Grumman) lowweak | Opp 1 Risk 2 | Thesis: The reviewed sources contain a descriptive article saying SpaceLogistics provides cooperative in-orbit satellite servicing using commercial servicing vehicles, which supports strategic relevance as a business category, but the only cited article is dated March 4, 2025 and was dropped by the 90-day recent evidence window. Why now: Why now is weak because the only cited article, March 4, 2025), falls outside the 90-day recent evidence window and was dropped; recency therefore does not support an active thesis here. Caveats: No evidence were kept after recent evidence filtering. Cannot rely on dropped 2025 evidence for a current ranking. Company-category relevance is not sufficient for a directional opportunity thesis. |
| 377 | Spaceworks lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources only says Momentus's fully booked Vigoride 8 mission will carry a Spaceworks COSMIC payload, which indicates some space-payload involvement but does not establish a durable company-specific opportunity thesis for Spaceworks. Why now: No within the recent evidence window retained catalyst is available. The phase-2 rationale references, but no, timestamp, or retained summary is included. Caveats: Support is provisional single-article context only. No retained direct evidence after recent evidence window. Payload mention does not prove company-level commercial traction. |
| 378 | Spacium lowweak | Opp 1 Risk 2 | Thesis: Spacium has a potentially attractive refueling/logistics angle, and an older article says it raised an oversubscribed $6.3 million seed round, but that dated evidence is outside the 90-day recent evidence window and therefore cannot support a current-ranked opportunity thesis. Why now: The only cited article is dated January 23, 2025, and the reviewed sources explicitly shows it was dropped by the 90-day recent evidence window cutoff of March 29, 2026. Caveats: All dated evidence was excluded by recent evidence window. Do not use out-of-window article as current recency proof. |
| 379 | SSC Space lowweak | Opp 1 Risk 1 | Thesis: No positive thesis is supportable from these reviewed sources because no direct positive evidence remains after recent evidence filtering. Why now: There is no retained within the recent evidence window evidence for a current catalyst. Caveats: Phase-2 rationale mentions a sponsored article and a partnership supporting Firefly's Blue Ghost lunar lander antennas, citing, but no or article summary is provided in these reviewed sources. Coverage debug shows 3 articles considered and 0 after recent evidence window. Sponsored-article context would be weaker than direct event/fact evidence even if fully provided. |
| 380 | ST Engineering lowweak | Opp 1 Risk 1 | Thesis: Only weak, supporting article context suggests ST Engineering had involvement in SAR and AI geospatial analytics for satellite ocean surveillance, but the reviewed sources contain no direct positive evidence after the 90-day recent evidence window and no article to substantiate a durable 1 year+ opportunity thesis (: not provided in reviewed sources). Why now: There is no usable dated direct evidence inside the recent evidence window; the reviewed sources explicitly shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, so recency-based timing is unsupported. Caveats: No direct evidence remained after the recent evidence filter. Representative articles are empty, so no is available in the reviewed sources. Membership rationale is weaker than company-specific event evidence. |
Risk view
Showing rows 341-360 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 341 | Nanoracks lowweak | Opp 2 Risk 1 | Thesis: No retained adverse evidence is provided. The main risk is evidentiary staleness rather than a documented business problem. Why now: There is no valid within the recent evidence window catalyst. The only company-specific article is at with September 2, 2025, and the reviewed sources say it was excluded by the 90-day cutoff. Evidence
Caveats: The only cited article is outside the selected 90-day evidence recent evidence window and therefore should not drive strong ranking. This is supporting source context, not merged serving evidence. No retained direct positive or negative evidence remain after recent evidence window. |
| 342 | NeevCloud lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supportable because no direct negative evidence survived the 90-day recent evidence window in the retained reviewed sources. Why now: Why now is weak: despite membership rationale referring to partnerships and orbital data center / AI inferencing context, the retained reviewed sources contain zero evidence after recent evidence window and no citable article summaries. Caveats: Phase-2 membership rationale references, and: but no summaries or direct evidence are retained here for factual claims. The reviewed sources itself says NeevCloud is space-adjacent and not clearly a qualifying space company. |
| 343 | NewOrbit lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources. Why now: No retained post-recent evidence window evidence are available, so current timing cannot be established from these reviewed sources. Caveats: Only membership rationale supports the company in this screen. No citeable retained evidence after recent evidence window. |
| 344 | OHB SE lowweak | Opp 1 Risk 1 | Thesis: No within the recent evidence window direct negative evidence was available, so there is insufficient reviewed sources support to form a material adverse thesis. Why now: There is no retained article or evidence row after the 90-day recent evidence window for OHB SE; recency-based ranking is therefore not supported by the reviewed sources. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase-2 cohort membership rationale is not directional evidence and cannot substitute for retained article evidence. Because no article were retained after recent evidence window, no company-specific factual thesis can be cited from these reviewed sources. |
| 345 | Optimized Electrotech Pvt Ltd lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window direct negative evidence was available, so a material risk thesis is not supported. Why now: No retained company evidence after the 90-day recent evidence window means there is no evidence-set-backed timing reason to rank this name higher now. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites article IDs, and, but no or retained evidence text are available here. Without retained article evidence, absence of bad news is not positive evidence. |
| 346 | OrbitOn lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is present, but because the only cited evidence is an older database-style listing that falls outside the recent evidence window, current execution and business-state risk cannot be assessed confidently. Why now: Why now is weak because the only visible article has March 4, 2025 on a source date basis and the reviewed sources report no current evidence was retained after the March 29, 2026 cutoff Evidence
Caveats: Only article detail shown is outside the 90-day recent evidence window and was dropped. Database/listing style evidence is weaker than company-specific event evidence. External supporting source context is relevance context, not stronger than direct retained evidence. |
| 347 | Paras Defence and Space Technologies Ltd lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supported within the reviewed sources' 90-day evidence window. Risk is low-scored because evidence is absent, not because business risk is disproven. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Paras Defence and Space Technologies Ltd. Caveats: Phase-2 membership rationale references article, but the reviewed sources does not provide or quoted evidence for that item, so it cannot be used as a factual directional citation. No direct positive or negative evidence survived the 90-day recent evidence window. |
| 348 | Parsons Corporation lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Parsons Corporation. Caveats: Phase-2 membership rationale references articles: and, but the reviewed sources provide no for citation. Article-level market-report inclusion is weaker than direct company-specific operating evidence. |
| 349 | PhysicsX lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is retained, so there is no supported material risk thesis either. Why now: There is no current catalyst evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0. Caveats: Funding-round context in rationale lacks -cited retained evidence here. Space relevance is explicitly weak in the reviewed sources rationale. |
| 350 | PierSight lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is supplied after recent evidence filtering, so a risk thesis is also not supported. Why now: Why now is unsupported because the reviewed sources show no surviving evidence after recent evidence filtering; there is no direct dated milestone or problem signal to anchor a 1 year+ thesis. Caveats: Only membership-level rationale is present; no citable evidence survived. No direct company-specific positive or negative events are available in the reviewed sources. Low scores reflect evidence scarcity. |
| 351 | Pilot Photonics lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is available; the main risk is that the reviewed sources lack retained direct evidence on timing, follow-on awards, or commercial conversion beyond the cited membership rationale. Why now: Why now is limited because only membership rationale references article: and the reviewed sources provide no or retained evidence after recent evidence window. Caveats: The ESA contract claim cannot be elevated strongly without the underlying article or summary in the reviewed sources. Coverage data shows evidence after recent evidence window 0. Opportunity may be real, but reviewed sources support is too sparse for higher conviction. |
| 352 | Pixxel lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources contain no retained adverse evidence within the recent evidence window, so there is no evidence-based risk thesis beyond execution uncertainty from being a private space startup with limited current reviewed sources support. Why now: Why now is weak because the only cited article summary in the reviewed sources are outside the 90-day evidence window, October 13, 2025 Caveats: The representative article for Pixxel is outside the recent evidence window and evidence recent evidence review shows kept_rows 0. No retained structured positive or negative rows are available. |
| 353 | Pixxel lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is retained, so there is no evidence-based negative thesis in these reviewed sources version. Why now: Why now is weak because no articles or evidence were retained after the March 29, 2026 cutoff in these reviewed sources version. Caveats: Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Membership rationale references article IDs without, which cannot be cited as factual support here. |
| 354 | Portal Space Systems lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window negative evidence was available, so the reviewed sources does not support a material risk view. Why now: There is no retained evidence inside the 90-day recent evidence window, so no current catalyst or business-state update is citable from these reviewed sources. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article IDs, and, but no or retained summaries are supplied. Low score reflects lack of citable evidence, not a negative business judgment. |
| 355 | Precursor SPC lowweak | Opp 1 Risk 1 | Thesis: No material negative thesis is supportable from retained evidence in these reviewed sources. Why now: Why now is weak because the reviewed sources show no available post-recent evidence window evidence; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0. Caveats: Phase-2 rationale references without or retained evidence detail, so it is not sufficient for factual grounding here. No direct positive or negative evidence arrays are populated. Low scores are an evidence-gap judgment, not a business conclusion. |
| 356 | Quantum Opus lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supported because the reviewed sources contain no direct negative evidence within the recent evidence window. Why now: There is no clear why-now catalyst because coverage after the 90-day recent evidence window is empty. Caveats: Membership support exists but no representative article is provided for. No retained evidence after recent evidence window. No direct business-state update, financing, contract, or customer traction evidence is available. |
| 357 | Quantum Systems GmbH lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is available. The reviewed sources does not provide material adverse company-specific facts within the recent evidence window. Why now: There is no supported near-term or long-horizon catalyst in the reviewed sources because zero post-recent evidence window evidence were available. Caveats: Phase2 rationale references article IDs: and: as article context only, but no were provided in the reviewed sources. Coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Context-only mentions and portfolio references cannot substitute for direct positive or negative evidence. |
| 358 | Rogers Communications Inc. lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supported by the reviewed sources. Risk is scored low only because evidence is absent, not because the company is de-risked. Why now: There is no available 90-day evidence for Rogers in these reviewed sources; coverage data shows zero article ids after recent evidence window and zero evidence after recent evidence window, so there is no supported 'why now' catalyst in the provided evidence. Caveats: No direct positive or negative evidence were available after the 90-day recent evidence window for Rogers. Phase2 rationale references support references including: but no article or article summary for that item is included in these reviewed sources, so it cannot be cited as factual evidence. Opportunity score is kept near zero because the evidence standard require positive evidence, not mere absence of risk. |
| 359 | Rogue Space Systems lowweak | Opp 2 Risk 1 | Thesis: No material negative development is documented in the retained reviewed sources; the principal risk is low evidence quality and lack of dated corroboration. Why now: The only retained evidence is an undated external sector page listing Rogue Space Systems as an operating in-orbit servicing company, so the why-now is weak and recency is uncertain. Evidence
Caveats: Evidence is undated and explicitly not recency proof per reviewed sources policy. Same-article repeated rows are not independent confirmation. No direct evidence of contracts, funding, milestones, or setbacks is included. |
| 360 | Romanian InSpace Engineering lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available, so no supported risk thesis exists beyond sparse-coverage uncertainty. Why now: No why-now catalyst is evidenced because there are no retained 90-day evidence. Caveats: Reviewed evidence references but provides no. Single historical membership-support mention only. No retained evidence after recent evidence window. |